Postexposure Prophylaxis for HIV Exposed Health Care Workers

Armstrong K. Gorden R. , & Santorella G. (1995). Occupational exposure of health care workers (HCWs) to human immunodeficiency virus (HIV): Stress reactions and counseling interventions. Social Work in Health Care, 21(3), 61–80.

Centers for Disease Control and Prevention. (1996). Provisional Public Health Service recommendations for chemoprophylaxis after occupational exposure to HIV. Morbidity and Mortality Weekly Report, 45(22), 468–472.

EPINet (1999). Exposure prevention information network data reports. Charlottesville. VA: University of Virginia, International Health Care Worker Safety Center.

McClinsey S.C. (1999). Occupational exposure to HIV: Considerations for postexposure prophylaxis and prevention. Nursing Clinics of North America, 34(1), 213–225.

National Institute for Occupational Safety and Health. (1999). NIOSH Alert: Preventing needlestick injuries in health care settings. (DHHS Publication No. 2000-108) [On-line]. Available: http://www.cdc.gov/niosh/2000-108.html

Busch M.P. , & Satten G.A. (1997). Time course of viremia and antibody seroconversion following HIV exposure. American Journal of Medicine, 102(Suppl. 5B), 117–124.

Cardo, D.M., Culver, D.H., Ciesielski, C.A., Srivastava, P.U., Marcus, R., Abiteboul, D., Heptonstall, J., Ippolito, G., Lot, F., McKibben, P.S., Bell, D.M., & CDC Surveillance Group. (1997). A case-control study of HIV seroconversion in health care workers after percutaneous exposure. New England Journal of Medicine, 337(21), 1485–1490.

Centers for Disease Control and Prevention. (1996). Provisional Public Health Service recommendations for chemoprophylaxis after occupational exposure to HIV. Morbidity and Mortality Weekly Report, 45(22), 468–472.

Ciesielski C.A. , & Metier R.P. (1997). Duration of time between exposure and seroconversion in healthcare workers with occupationally acquired infection with human immunodeficiency virus. American Journal of Medicine, 102(Suppl. 5B), 115–116.

D'Amico R. Pinto L. Meyer P. Landay A. Harris A.A. Clerici M. Berzofsky J.A. Shearer G.M. , & Kessler H.A. (1999). Effect of zidovudine postexposure prophylaxis on the development of HIV-specific cytotoxic T-lymphocyte responses in HIV-exposed healthcare workers. Infection Control and Hospital Epidemiology, 20(6), 428–430.

Sperling R.S. Shapiro D.E. Coombs R. Todd J.A. Herman S.A. McSherry G.D. O'Sulliva M.J. Van Dyke R.B. Jimenez E. Rouzioux C. Flynn P.M. , & Sullivan J.L. (1996). Maternal viral load, zidovudine treatment, and risk of transmission of human immunodeficiency virus type 1 from mother to infant. New England Journal of Medicine, 335(22), 1621–1629.